Mon. Sep 28th, 2020

Market and Financial News Aggregator

Akero Therapeutics started at overweight with $70 stock price target at Morgan Stanley

1 min read

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.






2020-09-10 11:30:30


Read more from source here…

Leave a Reply